|
| Press Releases |
|
 |
|
| Tuesday, August 7, 2012 |
|
|
Q&A: MediciNova CEO, Dr. Yuichi Iwaki on His Firm's Pipeline, Upcoming Milestones and Recent Clinical Trial Results |
| Dr. Yuichi Iwaki, President and CEO of Nasdaq listed small-cap MediciNova, Inc. (NASDAQ:MNOV) took the time to answer BioMedReports' questions about his firm's pipeline, upcoming milestones and recent clinical trial results. more info >> |
|
| Thursday, August 2, 2012 |
|
|
Amicus Therapeutics: Strong Catalyst Trade With GlaxoSmithKline And Heavy Insider Buying |
| I like to invest in and trade companies with strong corporate structures that are also equipped with upcoming short term catalysts. more info >> |
|
|
Doomed Dendreon? Many Speculators Shocked By Poor Sales Again |
| Dendreon (DNDN) has been a disastrous holding for many investors who may have been initially optimistic about the company's drug PROVENGE. more info >> |
|
| Wednesday, August 1, 2012 |
|
|
Former Chairman and CEO of Celgene Believes His New Firm Can Become "A Substantial Player" in Biotech |
| No doubt, one of the biggest biotech surprises out of the starting gate this year has been Medgenics Inc. (AMEX:MDGN). The stock ran big shortly after their introduction to the market as shares traded from $2.08 to $16.43 in short order-- an impressive run fueled in part by the company's extremely low float and excited reaction by investors. more info >> |
|
| Tuesday, July 31, 2012 |
|
|
Pluristem Therapeutics' New Indication for Pulmonary and Lung Disorders Expands Blockbuster Pipeline |
| This morning, Pluristem Therapeutics (NASDAQ:PSTI) is once again making news. This time, with a new way to treat Pulmonary fibrosis; where a person's lungs become so scarred that breathing is impossible. more info >> |
|
|
Pluristem's New Indication for Pulmonary and Lung Disorders Expands Blockbuster Pipeline |
| This morning, Pluristem Therapeutics (PSTI) is once again making news. This time with a new way to treat Pulmonary fibrosis; where a person's lungs become so scarred that breathing is impossible. It strikes 5 million people per year around the world, and 200,000 in the US. Most die because there is no cure. more info >> |
|
| Friday, July 27, 2012 |
|
|
Roth Capital Says Amarin's Approval Provides Visibility for Neptune Reiterates Buy Rating and $10.30 Price Target |
| In a flash note to clients on Friday, Roth Capital Partners' analyst Joseph Pantginis, Ph.D.,says that Thursday's FDA approval for Amarin Corporation's (NASDAQ:AMRN) Vascepa bodes well for Neptune Technologies & Bioressources' (Nasdaq:NEPT) (TSX:NTB) underlying and growing core NKO business as well as the pharmaceutical opportunity with Acasti's CaPre. more info >> |
|
| Thursday, July 26, 2012 |
|
|
Short Squeeze & Speculation Could Push Onyx and Ligand Higher |
| When I last covered Onyx Pharmaceuticals (NASDAQ:ONXX) on June 19th, the company was trading at a market capitalization of approximately $3 billion dollars ahead of a review of Kyprolis (carfilzomib) by the FDA's Oncologic Drugs Advisory Committee (ODAC). more info >> |
|
| Monday, July 23, 2012 |
|
|
Pluristem Poised To Benefit From The Evolution of Regulatory Requirements |
| Trying to find companies that represent the future of the biotech sector can be tricky for investors. The sector currently leads the market because Food and Drug Administration (FDA) regulatory guidance is changing, with restrictions easing, and new guidelines being proposed and implemented. more info >> |
|
|
New Reports Indicate That Brainstorm's Clinical Data is Compelling |
| While BrainStorm Cell Therapeutics (OTCBB:BCLI) is expected to officially release their highly anticipated clinical data to U.S. investors shortly, two widely distributed overnight reports point to strong progress in the results of their mid-stage clinical trials. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
韓国の主要人物・金載德氏がMOVA Chain支援を表明、エコシステム発展が新段階へ
Dec 13, 2025 13:00: JST
|
|
|
HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion
Dec 12, 2025 23:15 JST
|
|
|
京東工業登陸港交所：業績與品牌雙賦能 長期成長潛力可期
Dec 12, 2025 17:05 HKT/SGT
|
|
|
京东工业登陆港交所：业绩与品牌双赋能 长期成长潜力可期
Dec 12, 2025 17:04 HKT/SGT
|
|
|
京東工業配售結果出爐：MRO龍頭實力領跑 全鏈條數智化解決方案釋放長期價值
Dec 12, 2025 17:00 HKT/SGT
|
|
|
京东工业配售结果出炉：MRO龙头实力领跑 全链条数智化解决方案释放长期价值
Dec 12, 2025 17:00 HKT/SGT
|
|
|
全鏈條服務+業績高增長彰顯實力 京東工業港交所上市釋放長期價值
Dec 12, 2025 15:54 HKT/SGT
|
|
|
全链条服务+业绩高增长彰显实力 京东工业港交所上市释放长期价值
Dec 12, 2025 15:54 HKT/SGT
|
|
|
首隻山水實景表演概念股 印象大紅袍啟動香港公開募股
Dec 12, 2025 15:01 HKT/SGT
|
|
|
首只山水实景表演概念股 印象大红袍启动香港公开募股
Dec 12, 2025 15:00 HKT/SGT
|
|
|
Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten
Dec 12, 2025 14:35 HKT/SGT
|
|
|
雲頂新耀與海森生物簽署商業化服務協議及授權許可協議 推動商業化協同與多領域佈局
Dec 12, 2025 14:35 HKT/SGT
|
|
|
云顶新耀与海森生物签署商业化服务协议及授权许可协议 推动商业化协同与多领域布局
Dec 12, 2025 14:35 HKT/SGT
|
|
|
國泰海通成功發行非銀金融機構首單上海自貿離岸債
Dec 12, 2025 11:41 HKT/SGT
|
|
|
国泰海通成功发行非银金融机构首单上海自贸离岸债
Dec 12, 2025 11:41 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
